DMT1 polymorphism and risk of Parkinson's disease

被引:50
|
作者
He, Qing [1 ,2 ]
Du, Tingting [1 ,2 ]
Yu, Xiaojun [1 ,2 ]
Xie, Anmu [3 ]
Song, Ning [1 ,2 ]
Kang, Qi [1 ,2 ]
Yu, Jintai [4 ]
Tan, Lan [4 ]
Xie, Junxia [1 ,2 ]
Jiang, Hong [1 ,2 ]
机构
[1] Qingdao Univ, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Dept Physiol, Qingdao 266071, Peoples R China
[2] Qingdao Univ, State Key Disciplines Physiol, Coll Med, Qingdao 266071, Peoples R China
[3] Qingdao Univ, Hosp Med Coll, Dept Neurol, Qingdao 266071, Peoples R China
[4] Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China
关键词
Parkinson's disease; DMT1; Polymorphism; METAL TRANSPORTER 1; ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISORDERS; SUBSTANTIA-NIGRA; CANDIDATE GENE; IRON OVERLOAD; MUTATIONS; NRAMP2; PINK1; SUSCEPTIBILITY;
D O I
10.1016/j.neulet.2011.07.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Growing evidence suggests that iron accumulation in the substantia nigra (SN) is involved in the pathology of Parkinson's diseases (PD). Divalent metal transporter 1 (DMT1) is an endogenous transporter for ferrous iron, the levels of which are significantly increased in the SN in postmortem PD brains. To study the possible association of DMT1 gene with PD occurrence, one mutation (1303C/A) and two single nucleotide polymorphisms (SNPs) (1254T/C and IVS4 + 44C/A) in DMT1 gene were investigated in 192 PD patients in a Han Chinese population and 193 healthy controls by method of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Direct sequencing was performed in 10% of the samples to validate the genotyping results. Our results failed to find any significant association between the tested genotypes, alleles or mutation and PD, however, a haplotype (C alleles of 12541 and IVS4 + 44C/A polymorphisms) occurred at greater frequencies in PD subjects compared with that of control (18.2% versus 11.4%, OR = 1.72, 95% Cl = 1.15-2.59, P=0.01). These results suggest that CC haplotype in DMT1 gene is a possible risk factor for PD in this Han Chinese population. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:128 / 131
页数:4
相关论文
共 50 条
  • [1] Is the 1254T > C polymorphism in the DMT1 gene associated with Parkinson's disease?
    Saadat, Selva Moheb
    Degirmenci, Irfan
    Ozkan, Serhat
    Saydam, Faruk
    Koroglu, Zeynep Ozdemir
    Colak, Ertugrul
    Gunes, Hasan Veysi
    [J]. NEUROSCIENCE LETTERS, 2015, 594 : 51 - 54
  • [2] Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
    Salazar, Julio
    Mena, Natalia
    Hunot, Stephane
    Prigent, Annick
    Alvarez-Fischer, Daniel
    Arredondo, Miguel
    Duyckaerts, Charles
    Sazdovitch, Veronique
    Zhao, Lin
    Garrick, Laura M.
    Nunez, Marco T.
    Garrick, Michael D.
    Raisman-Vozari, Rita
    Hirsch, Etienne C.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (47) : 18578 - 18583
  • [3] Effect of DMT1 gene polymorphism on placental metal levels
    Kayaalti, Z.
    Tekin, D.
    Mergen, G.
    Odabasi, M.
    Kurtay, G.
    Soylemezoglu, T.
    [J]. TOXICOLOGY LETTERS, 2010, 196 : S160 - S161
  • [4] Role of the DMT1 gene polymorphism on manganese levels in placental tissues
    Tekin, Deniz
    Kayaalti, Zeliha
    Aliyev, Vugar
    Soylemezoglu, Tulin
    [J]. TOXICOLOGY LETTERS, 2012, 211 : S67 - S68
  • [5] The DMT1 IVS4+44C>A polymorphism and the risk of iron deficiency anemia in children with celiac disease
    Tolone, Carlo
    Bellini, Giulia
    Punzo, Francesca
    Papparella, Alfonso
    Miele, Erasmo
    Vitale, Alessandra
    Nobili, Bruno
    Strisciuglio, Caterina
    Rossi, Francesca
    [J]. PLOS ONE, 2017, 12 (10):
  • [6] A polymorphism in DMT1 is associated with lead-related hypertensive status
    Hyung-Ki Kim
    Hwayoung Lee
    Hak-Jae Kim
    [J]. Molecular & Cellular Toxicology, 2013, 9 : 415 - 420
  • [7] A polymorphism in DMT1 is associated with lead-related hypertensive status
    Kim, Hyung-Ki
    Lee, Hwayoung
    Kim, Hak-Jae
    [J]. MOLECULAR & CELLULAR TOXICOLOGY, 2013, 9 (04) : 415 - 420
  • [8] DMT1 and iron transport
    Yanatori, Izumi
    Kishi, Fumio
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2019, 133 : 55 - 63
  • [9] The iron transporter DMT1
    Andrews, NC
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (10): : 991 - 994
  • [10] α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson's Disease Models
    Bi, Mingxia
    Du, Xixun
    Jiao, Qian
    Liu, Zhiguo
    Jiang, Hong
    [J]. ACS CHEMICAL NEUROSCIENCE, 2020, 11 (11): : 1682 - 1691